Archer Daniels Midland
ADM
$75.84
-0.59%
Archer Daniels Midland Company (ADM) is a global agricultural processor and commodity trader, operating in the Consumer Defensive sector within the Agricultural Farm Products industry. Its core business involves processing oilseeds, corn, and wheat into food, feed, industrial, and energy products, and it operates a vast global logistics network for grain merchandising and storage. ADM is a dominant market leader and price-setter in global agricultural supply chains, distinguished by its massive scale, integrated infrastructure, and diversification into higher-margin nutrition and bio-solutions. The current investor narrative is dominated by volatile commodity prices impacting core processing margins and a strategic shift towards its higher-growth Nutrition segment, while the stock is also grappling with the aftermath of significant internal accounting investigations that have weighed on investor sentiment and management credibility.…
ADM
Archer Daniels Midland
$75.84
Investment Opinion: Should I buy ADM Today?
Rating & Thesis: Hold. ADM is a high-quality, defensive business with a strong balance sheet, but near-term cyclical headwinds and a valuation that already reflects a recovery make the risk/reward balanced at current levels. This aligns with the neutral-to-bearish lean of analyst sentiment and the average target price implying -11.8% downside.
Supporting Evidence: The primary valuation metric, the forward P/E of 14.2x, is reasonable but not compelling given the -13.7% YoY revenue decline and compressed margins. The stock trades at a premium to its historical median on a trailing basis (25.8x P/E). While free cash flow generation is strong at $4.2B TTM, quarterly profitability is under pressure, with Q4 net income of $456M down from $567M in the prior-year period. The implied upside to the average analyst target is negative, suggesting limited near-term capital appreciation potential.
Risks & Conditions: The two biggest risks are a deeper-than-expected downturn in commodity processing margins and a failure to improve profitability in the Nutrition segment. This Hold rating would upgrade to a Buy if the forward P/E compressed below 12x on sustained earnings growth or if revenue declines stabilized and turned positive. It would downgrade to a Sell if quarterly net margins fell below 2% or if the stock broke below key technical support near $70 on worsening fundamentals. Relative to its history and the earnings recovery priced in, the stock is fairly valued to slightly overvalued.
Sign up to view all
ADM 12-Month Price Forecast
The outlook for ADM is one of cautious stabilization. The company's defensive profile and financial strength are offset by clear cyclical pressures on earnings and revenue. The base case (55% probability) of range-bound trading around current levels is most likely, as the market awaits evidence of the promised earnings recovery. A move above $85 would require a decisive beat on earnings and resolution of company-specific overhangs, while a break below $70 would signal the bear case is unfolding. The stance would turn bullish on confirmation of margin expansion and sequential revenue growth; it would turn bearish on a breakdown of key technical support coupled with another quarter of negative operating cash flow.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Archer Daniels Midland's 12-month outlook, with a consensus price target around $98.59 and implied upside of +30.0% versus the current price.
Average Target
$98.59
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$61 - $99
Analyst target range
Analyst coverage for ADM appears limited, with only 3 analysts providing estimates, suggesting it may be under-followed relative to its market cap, which can lead to higher volatility and less efficient price discovery. The consensus sentiment, based on recent institutional ratings, leans bearish to neutral, with firms like JP Morgan and Morgan Stanley maintaining 'Underweight' or 'Equal Weight' stances, though UBS has a 'Buy' rating; the average target price implied by EPS estimates of $4.67 and a forward PE of 14.18x is approximately $66.20, which would imply a -11.8% downside from the current price of $75.10. The target range is wide, with estimated EPS spanning from $4.29 to $5.60, reflecting high uncertainty around commodity prices, segment performance, and the company's ability to execute its strategic shift; the low end of the range likely prices in continued margin pressure and execution risks, while the high end assumes a successful navigation of commodity cycles and growth in the Nutrition business.
Bulls vs Bears: ADM Investment Factors
The evidence presents a balanced but cautious picture, with the bearish arguments currently holding stronger weight due to deteriorating fundamentals. The bull case is built on a fortress balance sheet, attractive forward valuation, and a defensive profile, while the bear case highlights severe earnings pressure, an elevated trailing multiple, and skeptical analyst sentiment. The single most important tension in the investment debate is whether the company's robust financial health and strategic shift towards Nutrition can successfully offset the severe cyclical pressures and margin compression in its core commodity businesses. The resolution of this tension—specifically, the trajectory of earnings recovery versus the current high expectations embedded in the stock price—will determine the next major move.
Bullish
- Strong Financial Health & Cash Flow: ADM's balance sheet is exceptionally robust, with a current ratio of 11.2 indicating ample liquidity to weather downturns. The company generated $4.2 billion in trailing twelve-month free cash flow, providing significant flexibility for shareholder returns and strategic investments.
- Attractive Forward Valuation: The stock trades at a forward P/E of 14.2x, a significant discount to its trailing P/E of 25.8x, implying the market expects a substantial earnings recovery. This forward multiple is reasonable for a market leader in a defensive sector, especially given its strong cash generation.
- Defensive Profile with Low Beta: With a beta of 0.60, ADM exhibits 40% less volatility than the broader market, offering a defensive characteristic in uncertain economic climates. This low correlation is attractive for portfolio diversification, as evidenced by its 39% 1-year return outperforming the SPY's 25% gain.
- Strategic Shift to Higher-Margin Nutrition: The company's strategic pivot towards its higher-margin Nutrition segment aims to reduce cyclicality and improve profitability over the long term. This transition, if successful, could re-rate the stock's valuation multiple away from pure commodity processor levels.
Bearish
- Severe Earnings and Revenue Pressure: Q4 2025 revenue declined -13.7% YoY, continuing a sequential downtrend. Net margin compressed to 2.46% from 2.64% a year ago, and quarterly operating cash flow turned negative at -$313 million, highlighting fundamental cyclical pressures.
- Elevated Trailing Valuation: ADM's trailing P/E of 25.8x is high for a commodity processor, especially when compared to typical sector peers. This elevated multiple suggests the market has already priced in a significant earnings recovery, leaving little room for disappointment.
- Analyst Skepticism and Downside Target: Analyst consensus appears bearish/neutral, with firms like JP Morgan and Morgan Stanley maintaining 'Underweight' or 'Equal Weight' ratings. The average target price implied by a forward P/E of 14.2x and EPS of $4.67 is ~$66.20, representing an 11.8% downside from the current price.
- High Dependence on Volatile Commodities: Core Ag Services and Oilseeds revenue of $14.01B in Q4 2025 remains the dominant driver, making profits highly sensitive to volatile crop prices and processing margins. The gross margin of 6.54% in the latest quarter reflects this challenging, low-margin environment.
ADM Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 39.10% price increase, but is currently experiencing a near-term pullback from recent highs. As of the latest close of $75.10, ADM is trading approximately 88% of its 52-week range ($51.34 to $85.37), positioning it near the upper end of its annual band, which suggests the stock has significant momentum but may be susceptible to profit-taking after its strong run. The 1-month price change of -5.40% contrasts sharply with the positive 3-month (+13.50%) and 6-month (+28.95%) returns, indicating a recent deceleration and potential consolidation after a sharp rally earlier in the year, with the stock having peaked above $84 in early June. Key technical support is at the 52-week low of $51.34, while immediate overhead resistance lies near the 52-week high of $85.37; a decisive breakout above $85 would signal a resumption of the primary bull trend, whereas a break below the recent low near $75 could indicate a deeper correction. With a beta of 0.60, ADM has exhibited approximately 40% less volatility than the broader market (SPY), which is characteristic of a defensive staple but notable given its large price moves, suggesting idiosyncratic company-specific factors are currently driving price action more than systemic market risk.
Beta
0.60
0.60x market volatility
Max Drawdown
-12.8%
Largest decline past year
52-Week Range
$51-$85
Price range past year
Annual Return
+43.6%
Cumulative gain past year
| Period | ADM Return | S&P 500 |
|---|---|---|
| 1m | -2.2% | -1.6% |
| 3m | +5.8% | +11.7% |
| 6m | +31.3% | +6.3% |
| 1y | +43.6% | +22.2% |
| ytd | +28.4% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ADM Fundamental Analysis
ADM's revenue trajectory shows signs of pressure, with Q4 2025 revenue of $18.56 billion representing a -13.7% year-over-year decline, continuing a trend of sequential quarterly decreases from $21.19 billion in Q2 2025. The Ag Services and Oilseeds segment, at $14.01 billion in the latest period, remains the dominant revenue driver, but the overall decline points to softer commodity prices and volumes. Profitability remains positive but compressed, with Q4 2025 net income of $456 million and a net margin of 2.46%, a sequential improvement from Q3's $108 million (0.53% margin) but still below the stronger $567 million (2.64% margin) reported in Q4 2024; gross margin for the quarter was 6.54%, reflecting the challenging pricing environment in its core processing businesses. The balance sheet is robust with a strong current ratio of 11.20 and a moderate debt-to-equity ratio of 0.37, indicating ample liquidity and manageable leverage, while trailing twelve-month free cash flow of $4.20 billion provides significant financial flexibility for dividends, buybacks, and investments, though quarterly operating cash flow has been volatile, turning negative at -$313 million in Q4 2025 due to working capital movements.
Quarterly Revenue
$18.6B
2025-12
Revenue YoY Growth
-0.13%
YoY Comparison
Gross Margin
+0.06%
Latest Quarter
Free Cash Flow
$4.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ADM Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. ADM's trailing PE ratio is 25.78x, while its forward PE is significantly lower at 14.18x, indicating the market expects a substantial rebound in earnings over the next year. Compared to sector averages, ADM's trailing PE of 25.78x appears elevated against typical Consumer Defensive/Agricultural Product peers, suggesting the market may be assigning a premium based on its integrated model and cash flow stability, or that its earnings are cyclically depressed. Historically, the stock's own PE ratio has fluctuated widely, from a low near 10x in late 2024 to highs above 65x in mid-2025 during an earnings trough; the current 25.78x multiple sits above the median of its recent historical range, indicating the stock is not cheap on an absolute historical basis and that expectations for an earnings recovery are already partially priced in.
PE
25.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 9x~400x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: ADM faces significant earnings volatility driven by its core commodity processing businesses, as evidenced by a net margin that compressed to 2.46% in Q4 2025 from 2.64% a year prior and quarterly operating cash flow turning negative at -$313 million. Revenue concentration in the volatile Ag Services and Oilseeds segment ($14.01B of $18.56B total in Q4) creates dependence on crop prices and global trade flows. While the balance sheet is strong (D/E of 0.37), the high payout ratio of 91.6% could pressure the dividend if earnings fail to recover as anticipated.
Market & Competitive Risks: The stock's trailing P/E of 25.8x appears elevated for a commodity processor, creating valuation compression risk if the expected earnings rebound falters. With a beta of 0.60, ADM is less sensitive to broad market moves but is highly exposed to idiosyncratic commodity and company-specific risks, such as the ongoing accounting investigation. Competitive pressures and the capital-intensive nature of the industry limit pricing power, as reflected in the slim gross margin of 6.54%.
Worst-Case Scenario: A combination of sustained weak commodity prices, failed execution in the Nutrition segment, and a loss of investor confidence from the accounting issues could trigger a severe de-rating. This scenario could see the stock re-test its 52-week low of $51.34, representing a potential downside of approximately -32% from the current price of $75.10. Further downside toward the $40s is plausible if earnings estimates are cut significantly, given the wide analyst EPS range of $4.29 to $5.60.
FAQ
The key risks are, in order of severity: 1) Commodity & Operational Risk: Exposure to volatile agricultural prices and processing margins, evidenced by a gross margin of just 6.54% and a -13.7% YoY revenue drop. 2) Execution & Sentiment Risk: The overhang from internal accounting investigations threatens management credibility and could limit multiple expansion. 3) Valuation Risk: The elevated trailing P/E of 25.8x creates compression risk if earnings disappoint. 4) Macro & Competitive Risk: Economic slowdowns can reduce demand, while the capital-intensive industry limits pricing power.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $66 and $75, as it grinds along with modest earnings recovery in line with the $4.67 EPS consensus. The Bull Case (25% probability) projects a move to $85-$95 on a strong earnings beat toward the $5.60 EPS high estimate and resolved overhangs. The Bear Case (20% probability) warns of a drop to $51-$60 if cyclical pressures worsen and earnings fall toward the $4.29 low estimate. The base case is most likely, hinging on the assumption that the company meets current subdued analyst expectations.
ADM's valuation sends mixed signals. Its trailing P/E of 25.8x appears elevated relative to historical norms for a commodity processor and suggests the stock is not cheap. However, its forward P/E of 14.2x indicates the market is pricing in a significant earnings recovery. Compared to the analyst-derived average target price of ~$66.20, the stock appears slightly overvalued. The market is currently paying a fair-to-full price for the anticipated rebound, leaving little margin of safety if the recovery is delayed or weaker than expected.
ADM presents a mixed risk/reward profile at its current price of $75.10. For investors seeking a defensive, dividend-paying stock with a strong balance sheet, it could be a reasonable hold. However, with analyst targets implying an 11.8% downside and near-term earnings facing clear headwinds (-13.7% YoY revenue decline), it is not an compelling buy for growth-oriented investors. It may be a good buy for patient, income-focused investors only if acquired at a lower price, closer to the $66 analyst average target or if clear evidence of an earnings turnaround emerges.
ADM is more suitable for a long-term (3+ year) investment horizon. Its low beta (0.60) and 3.55% dividend yield support a buy-and-hold income strategy, while the strategic shift to Nutrition is a multi-year story. The stock's near-term path is clouded by cyclical earnings pressure and company-specific overhangs, making it a poor candidate for short-term trading. Investors should be prepared for volatility but can rely on the strong balance sheet and cash flow for downside protection. A minimum holding period of 2-3 years is suggested to allow the earnings cycle to turn and the strategic initiatives to bear fruit.